For instance, a prominent Th1/Th2 phenotype shift, expansion of myeloid-derived suppressor cells (MDSC), tumor-associated macrophages (TAMs), decreased CD8+ T cells, along with increased representation of certain inflammatory mediators such as IL-6, IL-17 contribute to tumor advancement. The gene discussed is IL17A; the disease is neoplasm.